Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive MelanomaNienke van Rooij, Ton N. Schumacher, Marja Nieuwland et al.|Journal of Clinical Oncology|2013Cited by 799
Targeting of cancer neoantigens with donor-derived T cell receptor repertoiresErlend Strønen, Ton N. Schumacher, Mireille Toebes et al.|Science|2016Cited by 448
TIL therapy broadens the tumor-reactive CD8<sup>+</sup>T cell compartment in melanoma patientsPia Kvistborg, Ton N. Schumacher, Chengyi J. Shu et al.|OncoImmunology|2012Cited by 176
Antigen‐specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapySander Kelderman, Nina Schumacher, Bianca Heemskerk et al.|European Journal of Immunology|2016Cited by 41
HLA Micropolymorphisms Strongly Affect Peptide–MHC Multimer–Based Monitoring of Antigen-Specific CD8+ T Cell ResponsesMarit M. van Buuren, Ton N. Schumacher, Carsten Linnemann et al.|The Journal of Immunology|2013Cited by 16